Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Synthesis and Pharmacological Evaluation of Novel C-8 Substituted Tetrahydroquinolines as Balanced-Affinity Mu/Delta Opioid Ligands for the Treatment of Pain.
ACS Chem Neurosci. 2018 Jul 18;9(7):1840-1848. doi: 10.1021/acschemneuro.8b00139. Epub 2018 May 2.
ACS Chem Neurosci. 2018.
PMID: 29677442
Free PMC article.
Opioid peptidomimetics: leads for the design of bioavailable mixed efficacy μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands.
Mosberg HI, Yeomans L, Harland AA, Bender AM, Sobczyk-Kojiro K, Anand JP, Clark MJ, Jutkiewicz EM, Traynor JR.
Mosberg HI, et al. Among authors: harland aa.
J Med Chem. 2013 Mar 14;56(5):2139-49. doi: 10.1021/jm400050y. Epub 2013 Feb 27.
J Med Chem. 2013.
PMID: 23419026
Free PMC article.
Item in Clipboard
Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.
Harland AA, Yeomans L, Griggs NW, Anand JP, Pogozheva ID, Jutkiewicz EM, Traynor JR, Mosberg HI.
Harland AA, et al.
J Med Chem. 2015 Nov 25;58(22):8952-69. doi: 10.1021/acs.jmedchem.5b01270. Epub 2015 Nov 13.
J Med Chem. 2015.
PMID: 26524472
Free PMC article.
Item in Clipboard
Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) Ligands.
Harland AA, Bender AM, Griggs NW, Gao C, Anand JP, Pogozheva ID, Traynor JR, Jutkiewicz EM, Mosberg HI.
Harland AA, et al.
J Med Chem. 2016 May 26;59(10):4985-98. doi: 10.1021/acs.jmedchem.6b00308. Epub 2016 May 16.
J Med Chem. 2016.
PMID: 27148755
Free PMC article.
Item in Clipboard
Placement of Hydroxy Moiety on Pendant of Peptidomimetic Scaffold Modulates Mu and Kappa Opioid Receptor Efficacy.
Harland AA, Pogozheva ID, Griggs NW, Trask TJ, Traynor JR, Mosberg HI.
Harland AA, et al.
ACS Chem Neurosci. 2017 Nov 15;8(11):2549-2557. doi: 10.1021/acschemneuro.7b00284. Epub 2017 Aug 25.
ACS Chem Neurosci. 2017.
PMID: 28796483
Free PMC article.
Item in Clipboard
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.
Kaski SW, White AN, Gross JD, Trexler KR, Wix K, Harland AA, Prisinzano TE, Aubé J, Kinsey SG, Kenakin T, Siderovski DP, Setola V.
Kaski SW, et al. Among authors: harland aa.
J Pharmacol Exp Ther. 2019 Nov;371(2):487-499. doi: 10.1124/jpet.118.255661. Epub 2019 Sep 6.
J Pharmacol Exp Ther. 2019.
PMID: 31492823
Free PMC article.
Item in Clipboard
A 5-HT(2C) receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference.
McCorvy JD, Harland AA, Maglathlin R, Nichols DE.
McCorvy JD, et al. Among authors: harland aa.
Neurosci Lett. 2011 Nov 7;505(1):10-3. doi: 10.1016/j.neulet.2011.07.036. Epub 2011 Jul 30.
Neurosci Lett. 2011.
PMID: 21827831
Free PMC article.
Item in Clipboard
Cite
Cite